Midodrine is a medication used to treat low blood pressure that drops when standing (orthostatic hypotension). It is available as a generic pill in a 2.5 mg strength and is marketed under brand names such as Agalat. In Hong Kong, midodrine is a prescription (Rx) drug regulated by the Department of Health.
Midodrine is a pro-drug that is converted by the body into its active form, desglymidodrine. The active metabolite stimulates α₁-adrenergic receptors on blood vessel walls. This stimulation causes the smooth muscle to contract, leading to vasoconstriction (narrowing of the blood vessels).
By increasing peripheral vascular resistance, midodrine raises standing systolic blood pressure and helps reduce symptoms such as dizziness, light-headedness, and fainting.
Midodrine is approved in Hong Kong for the treatment of symptomatic orthostatic hypotension when non-pharmacologic measures (e.g., compression stockings, fluid intake) are insufficient.
No other FDA/EMA-type approved indications for midodrine have been documented; use for other conditions is considered off-label and should only occur under specialist supervision.
Current peer-reviewed research does not provide strong evidence for routine off-label use of midodrine in conditions such as chronic fatigue syndrome or dialysis-related hypotension. If a clinician contemplates an off-label application, it must be based on individual risk assessment and documented clinical rationale.
Off-label use requires medical supervision and individualized risk assessment.
Patients should inform their healthcare provider of all medications, supplements, and herbal products before starting midodrine.
Dosing must be individualized by a healthcare provider.
Regular follow-up appointments (typically every 2-4 weeks during titration) help ensure safe and effective therapy.
This article provides educational information about midodrine and is not a substitute for professional medical advice. Treatment decisions, including use for unapproved indications, must be made under the guidance of a qualified healthcare provider. The content is intended for informational purposes and does not constitute medical recommendations. Always consult a physician before starting, stopping, or changing any medication regimen.
Midodrine should be taken during waking hours and avoided within 4 hours of bedtime to reduce the risk of supine hypertension, which can be dangerous while lying flat.
If dizziness persists, check your standing blood pressure. Contact your healthcare provider for possible dose adjustment or additional evaluation.
There are no specific food restrictions, but high-salt meals may amplify blood-pressure effects. Consistency in diet helps maintain stable readings.
Most patients experience a reduction in dizziness within a few days of starting therapy, though full benefit may require dose titration over 1-2 weeks.
Yes. Midodrine can raise blood pressure, so concurrent use with antihypertensives may blunt its effect, while use with other vasoconstrictors may cause excessive hypertension. Discuss all medications with your provider.
Air travel is generally safe, but stay hydrated, move your legs frequently, and monitor blood pressure, especially after long flights. Avoid dosing within 4 hours of sleeping on the plane.
Symptoms include severe hypertension, headache, anxiety, and rapid heartbeat. Seek emergency medical care immediately if these occur.
Midodrine is excreted renally; dose adjustments may be necessary for impaired kidney function. Your doctor may start at a lower dose and monitor renal labs.
Midodrine acts directly on blood-vessel receptors to cause vasoconstriction, whereas fludrocortisone increases blood volume by retaining sodium and water. The two have different mechanisms, side-effect profiles, and are selected based on individual patient needs.
